SCHEMBL28661925

SCHEMBL28661925

Cc1cc(C2=CCN(C(=O)O)CC2)nn1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.40
TP53 P04637 1/20 0.38
QDPR P09417 2/20 0.37
GRM1 Q13255 3/20 0.36
GRM5 P41594 2/20 0.36
SHMT2 P34897 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 2/20 0.36
NR2E1 Q9Y466 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
BAZ2B Q9UIF8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31053177 0.82 GRM1 (0.53) NAMPTGRM1GRM5
SCHEMBL28672701 0.77 JMJD6 (0.41) TP53QDPRGRM1GRM5SHMT2
SCHEMBL18865732 0.76 ALDH1A1 (0.39) NAMPTQDPRGRM1GRM5SMN1; SMN2
SCHEMBL15025632 0.76 CCR1 (0.49) NAMPTQDPRGRM1GRM5SMN1; SMN2
SCHEMBL16992268 0.73 ALDH1A1 (0.39) NAMPTTP53QDPRGRM1GRM5
SCHEMBL30711189 0.72 RAB9A (0.44) GRM1GRM5SMN1; SMN2ALDH1A1MEN1
SCHEMBL20140095 0.72 HTR1A (0.54) GRM1GRM5SMN1; SMN2ALDH1A1MEN1
SCHEMBL28791729 0.71 QDPR (0.42) NAMPTTP53QDPRSHMT2SMN1; SMN2
SCHEMBL3256667 0.70 SMN1; SMN2 (0.42) NAMPTTP53QDPRSMN1; SMN2ALDH1A1
SCHEMBL16423118 0.70 GRM1 (0.39) NAMPTQDPRGRM1GRM5SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113735825-A 1,2,3, 6-tetrahydropyridine compound and preparation method and application thereof 成都康弘药业集团股份有限公司 2021-12-03 CN disclosed